Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.84 is 11% below its 4-year average of 0.94, near the low end of its 4-year range (0.71–1.80).
As of the fiscal period ended Tuesday, June 30, 2026. 1.98% below its 12-month average of 0.85.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.84.
CURRENT RATIO
0.84
CURRENT RATIO AVG TTM
0.85
CURRENT RATIO AVG 3Y
0.88
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1.98%
CURRENT VS 3Y AVG
-5.51%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-77.73%
vs the sector median at left
Indivior Pharmaceuticals Inc
Market Cap
$4.44B
Current Ratio
0.84
TTM Avg
0.85
3Y Avg
0.88
5Y Avg
N/A
Market Cap
$4.43B
Current Ratio
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$4.39B
Current Ratio
4.79
TTM Avg
3.12
3Y Avg
4.00
5Y Avg
4.41
Market Cap
$4.30B
Current Ratio
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
Market Cap
$4.69B
Current Ratio
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.46
Market Cap
$4.69B
Current Ratio
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.73B
Current Ratio
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.44B | 0.84 | 0.85 | 0.88 | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | 5.08 | 3.83 | 4.06 | 4.06 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | 4.79 | 3.12 | 4.00 | 4.41 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.30B | 16.24 | 19.89 | 20.20 | 22.94 |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 1.47 | 1.61 | 1.69 | 1.64 |
| BillionToOne, Inc. (BLLN)vs › | $4.68B | 11.69 | 9.86 | 7.15 | 7.15 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 1.38 | 1.51 | 1.37 | 1.46 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | 6.95 | 6.77 | 6.23 | 10.87 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.73B | 26.10 | 14.27 | 14.23 | 14.47 |
| LivaNova PLC (LIVN)vs › | $4.13B | 1.45 | 2.12 | 2.54 | 2.24 |
Current Ratio
0.84
Quick Ratio
0.66
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.84 |
| 2026-03-31 | 0.86 |
| 2025-12-31 | 0.71 |
| 2025-09-30 | 0.96 |
| 2025-06-30 | 0.90 |
| 2025-03-31 | 0.88 |
| 2024-12-31 | 0.89 |
| 2024-09-30 | 0.83 |
| 2024-06-30 | 0.85 |
| 2024-03-31 | 0.92 |
| 2023-12-31 | 0.98 |
| 2023-09-30 | 0.98 |
| 2023-06-30 | 1.13 |
| 2023-03-31 | 1.08 |
| 2022-12-31 | 1.24 |
| 2022-09-30 | 1.70 |
| 2022-06-30 | 1.70 |
| 2022-03-31 | 1.73 |
| 2021-12-31 | 1.80 |
